« Previous
Next »
Titles
- FAQs: what's the latest on IPAB?1
- FDA categorization of investigational device exemption (IDE) devices to assist the Centers for Medicare and Medicaid Services (CMS) with coverage decisions: guidance for sponsors, clinical investigators, industry, institutional review boards, and Food and Drug Administration staff1
- FDA medical device reviews: evaluation is needed to assure requests for additional information follow a least burdensome approach : report to Congressional requestors1
- FDA oversight of tobacco manufacturing establishments1
- FY 2018 medical device user fee small business qualification and certification: guidance for industry, Food and Drug Administration staff and foreign governments1
- Factors affecting states' ability to respond to federal Medicaid cuts and caps: which states are most at risk?1
- Federal disaster assistance: FEMA's progress in aiding individuals with disabilities could be further enhanced : report to Congressional requesters1
- Federal employees health benefits program: enrollment remains concentrated despite more plan offerings, and effects of adding plan types are uncertain : report to the ranking member, Committee on Oversight and Government Reform, House of Representatives1
- Federal low-income programs: eligibility and benefits differ for selected programs due to complex and varied rules : report to the Chairman, Committee on the Budget, U.S. Senate1
- Federal subsidies for health insurance coverage for people under age 65: 2017 to 20271
- Financing family planning services for low income women: the role of public programs1
- FirstNet: efforts to establish the public-safety broadband network : testimony before the Subcommittee on Emergency Preparedness, Response, and Communications, Committee on Homeland Security, House of Representatives1
- Followup review: CMS's management of the quality payment program1
- Food Safety: a national strategy is needed to address fragmentation in federal oversight : report to Congressional requesters1
- Food allergy in the United States: recent trends and costs : an analysis of private claims data1
- Food safety: FDA continues to evaluate and respond to business concerns about the produce rule : report to Congressional committees1
- Form FDA 3674--certifications to accompany drug, biological product, and device applications/submissions: guidance for sponsors, industry, researchers, investigators, and food and drug administration staff1
- Formal dispute resolution: sponsor appeals above the division level : guidance for industry and review staff : good review practice1
- Foster care: HHS has taken steps to support states' oversight of psychotropic medications, but additional assistance could further collaboration : report to Congressional requesters1
- Frequent monitoring and behavioral assessment: keys to the care of the intoxicated patient1